News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gemmus Pharma to Present Details on New Host-Based Approach to Infectious Disease/Flu Therapies at the Biotechnology Industry Organization (BIO) Investor Forum, San Francisco on October 8th


10/7/2013 7:46:14 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Gemmus Pharma, a biotechnology company developing improved treatments for infectious diseases, will present data at this year’s BIOInvestor Forum. The talk titled “GP1681: A New Host-targeted Influenza Therapy”, will be given by Daryl Faulds, Ph.D., Co-founder and CEO of Gemmus, on Tuesday October 8, at 8:45 am. The BIOInvestor Forum will be held at the Palace Hotel, San Francisco.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES